Evidence map›Paper›PMID 27142448›Full record

Trial reportNutrition journal2016

Effects of green tea consumption on cognitive dysfunction in an elderly population: a randomized placebo-controlled study.

Kazuki Ide, Hiroshi Yamada, Norikata Takuma, Yohei Kawasaki, Shohei Harada, Junpei Nakase, Yuuichi Ukawa, Yuko M Sagesaka

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrition journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06604390 (THE EFFECTS OF GAMBIR CATECHIN), which is not on this map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06604390 nacompletednot on this mapstarted 2024, after this paper: background citation

The effects of gambir catechin (uncaria gambir roxb) supplementation on cognitive function, expression of amyloid precursor protein (app), microtubule associated protein tau (mapt), brain-derived neurotrophic factor (bdnf), interleukin 10 (il-10), transforming growth factor-beta (tgf-beta), and plasma malondialdehyde (mda) levels in the elderly

TypeinterventionalSponsorRahmi Novita YusufRan2024 to 2024Enrolled64ConditionsElderly Individuals Aged 60 Years or Older, Mild Cognitive Impairment (MCI)Armscatechin extracts (health food), plasebo
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Standardized Grape (Foods (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kazuki IdeDepartment of Drug Evaluation & Informatics, Graduate school of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Hiroshi YamadaDepartment of Drug Evaluation & Informatics, Graduate school of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan. hyamada@u-shizuoka-ken.ac.jp.
Norikata TakumaWhite Cross Nursing Home, 2-26-1 Suwa-cho, Higashimurayama, Tokyo, 189-0021, Japan.
Yohei KawasakiDepartment of Drug Evaluation & Informatics, Graduate school of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Shohei HaradaDepartment of Drug Evaluation & Informatics, Graduate school of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, 422-8526, Japan.
Junpei NakaseCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka, 421-0516, Japan.
Yuuichi UkawaCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka, 421-0516, Japan.
Yuko M SagesakaCentral Research Institute, ITO EN, Ltd., 21 Mekami, Makinohara, Shizuoka, 421-0516, Japan.
University of Shizuoka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGreen tea is a beverage with potential effects on cognitive dysfunction, as indicated by results of experimental studies. However, its effects in humans, especially at real-world (typical) consumption levels, are unclear.

methodsA double-blind, randomized controlled study was conducted to assess the effects of green tea consumption on cognitive dysfunction (Mini-Mental State Examination Japanese version (MMSE-J) score <28) in Japan. Participants were randomly allocated to the green tea or placebo group, and consumed either 2 g/day of green tea powder (containing 220.2 mg of catechins) or placebo powder (containing 0.0 mg of catechins), respectively, for 12 months. Cognitive function assessments were performed every 3 months using the MMSE-J and laboratory tests.

resultsThirty-three nursing home residents with cognitive dysfunction were enrolled (four men, 29 women; mean age ± SD, 84.8 ± 9.3; mean MMSE-J score ± SD, 15.8 ± 5.4), of whom 27 completed the study. Changes of MMSE-J score after 1 year of green tea consumption were not significantly different compared with that of the placebo group (-0.61 [-2.97, 1.74], least square mean (LSM) difference [95 % CI]; P = 0.59). However, levels of malondialdehyde-modified low-density lipoprotein (U/L), a marker of oxidative stress, was significantly lower in the green tea group (-22.93 [-44.13, -1.73], LSM difference [95 % CI]; P = 0.04).

conclusionsOur results suggest that 12 months green tea consumption may not significantly affect cognitive function assessed by MMSE-J, but prevent an increase of oxidative stress in the elderly population. Additional long-term controlled studies are needed to clarify the effects.

trial registrationUMIN000011668.

Indexed as

TeaAgedAged, 80 and overCatechinCognitionCognitive DysfunctionDouble-Blind MethodFemaleHumansJapanMaleNursing HomesOxidative StressPlacebosPlant ExtractsSurveys and QuestionnairesCatechinPlacebosPlant ExtractsTeaCognitive functionElderlyGreen teaOral administrationRandomized-controlled trial

Identifiers

PMID27142448
PMCPMC4855797
OpenAlexW2346629953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.